Drug intelligence / Profile preview

Alaquin

Development stage
Unknown
Lead developer
Primus Pharmaceuticals
Modality
Small Molecules
Administration
Topical
01

Overview

**Alaquin** is a brand name for a topical combination medication containing **clioquinol** (also known as iodochlorhydroxyquin, 1.25-3%) and **hydrocortisone** (1%, a mild corticosteroid), used to treat inflammatory skin conditions accompanied by fungal or bacterial infections, such as eczema, ringworm, athlete's foot, and jock itch. Clioquinol acts as an anti-infective agent with antifungal and antibacterial properties by preventing microbial growth, while hydrocortisone reduces swelling, redness, and itching through anti-inflammatory effects. It is manufactured by companies including Primus Pharmaceuticals and Sonar Products (discontinued in the US), or Crown Laboratories; apply thinly to affected skin 2-4 times daily, avoiding eyes, mucous membranes, and long-term use due to risks like skin thinning or staining. Not for viral infections like herpes or tuberculosis of the skin; safe for children over 2 years under medical supervision.[2][3][10]

Brand names
Alaquin
Other names
Ala-Quin
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on Alaquin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alaquin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call